Nonmyeloablative allogeneic peripheral blood stem-cell transplantation as immunotherapy for malignant diseases.
Childs
R W
RW
National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
D002292:Carcinoma, Renal Cell / Q000473:pathology / Q000628:therapy; D005819:Genetic Markers; D006086:Graft vs Host Disease / Q000276:immunology / Q000473:pathology; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D019337:Hematologic Neoplasms / Q000628:therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D007680:Kidney Neoplasms / Q000473:pathology / Q000628:therapy; D008175:Lung Neoplasms / Q000473:pathology / Q000556:secondary; D008297:Male; D008545:Melanoma / Q000628:therapy; D008875:Middle Aged; D018598:Minisatellite Repeats; D013601:T-Lymphocytes / Q000378:metabolism; D013997:Time Factors; D014184:Transplantation, Homologous / Q000379:methods*
D005819:Genetic Markers; D016179:Granulocyte Colony-Stimulating Factor